SB

Samsara BioCapital Portfolio holdings

AUM $489M
1-Year Est. Return 135.25%
This Quarter Est. Return
1 Year Est. Return
+135.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$484M
AUM Growth
+$19.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$70.8M
2
+$6.87M
3
+$3.67M
4
INZY
Inozyme Pharma
INZY
+$2.89M
5
LPTX icon
Leap Therapeutics
LPTX
+$288K

Top Sells

1
+$2.95M
2
+$2.16M
3
+$1.47M
4
SWTX
SpringWorks Therapeutics
SWTX
+$578K
5
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$153K

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$119M 24.7%
5,161,888
2
$70.8M 14.63%
+4,519,361
3
$36.8M 7.6%
4,598,828
4
$28M 5.79%
909,579
-47,872
5
$20.7M 4.28%
1,208,473
6
$19.8M 4.08%
2,260,652
7
$16.7M 3.45%
686,835
-121,206
8
$14.7M 3.03%
1,620,687
9
$14M 2.88%
695,001
10
$12.9M 2.67%
1,409,409
+750,000
11
$10.2M 2.1%
2,868,035
12
$10.1M 2.08%
609,862
-200
13
$8.6M 1.78%
640,688
14
$7.96M 1.65%
651,050
15
$7.74M 1.6%
1,675,579
16
$6.52M 1.35%
1,693,736
17
$6.16M 1.27%
345,293
18
$5.81M 1.2%
202,773
19
$5.78M 1.2%
470,304
20
$5.63M 1.16%
696,171
21
$4.44M 0.92%
304,715
22
$4.36M 0.9%
360,414
23
$4M 0.83%
80,963
24
$3.67M 0.76%
+1,750,000
25
$3.57M 0.74%
35,545
1
2 3